| Bioactivity | Protease-Activated Receptor-1 antagonist 1 (Compound 13) is a protease-activated receptor-1 (PAR-1) antagonist with the IC50 of 3 nM by FLIPR technology. Protease-Activated Receptor-1 antagonist 1 can be used for the research of thrombotic cardiovascular, myocardial infarction, and peripheral arterial disease[1]. |
| Name | Protease-Activated Receptor-1 antagonist 1 |
| Formula | C25H24F2N2O3 |
| Molar Mass | 438.47 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Mihirbaran Mandal, et al. Lead Optimization to Advance Protease-Activated Receptor-1 Antagonists in Early Discovery. J Med Chem. 2022 Apr 14;65(7):5575-5592. |
Protease-Activated Receptor-1 antagonist 1
CAS: F: C25H24F2N2O3 W: 438.47
Protease-Activated Receptor-1 antagonist 1 (Compound 13) is a protease-activated receptor-1 (PAR-1) antagonist with the
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.